- C4 Therapeutics (CCCC) has priced its upsized IPO of 9.6M shares of common stock at $19/share, for gross proceeds of $182.4M.
- The company initially planned to offer 8.824M shares at a price range of $16-$18.
- Underwriters' over-allotment is an additional 1.44M shares.
- Trading commences October 2. Closing date is October 6.
- https://seekingalpha.com/news/3619267-c4-therapeutics-prices-upsized-ipo-above-range-19
Friday, October 2, 2020
C4 Therapeutics prices upsized IPO above range at $19
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.